Prescribed to 4,500+ people since 2018
Including 130+ pediatric patients as young as 2 years of age since 2023*
Every person with hereditary angioedema (HAE) has a story to share. See how these people are choosing to reimagine their lives with TAKHZYRO. Individual experiences may vary.
*The number of patients prescribed TAKHZYRO is based on third-party US specialty pharmacy data.